786 related articles for article (PubMed ID: 18487007)
21. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
22. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
Klatte T; Patard JJ; Wunderlich H; Goel RH; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
J Urol; 2007 Jun; 177(6):2081-6; discussion 2086-7. PubMed ID: 17509291
[TBL] [Abstract][Full Text] [Related]
23. Metachronous renal tumours after surgical management of oncocytoma.
Childs MA; Breau RH; Umbreit EC; Lohse CM; Cheville JC; Thompson RH; Blute ML; Leibovich BC
BJU Int; 2011 Sep; 108(6):816-9. PubMed ID: 21166765
[TBL] [Abstract][Full Text] [Related]
24. Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients.
Klatte T; Seitz C; Waldert M; de Martino M; Kikic Z; Böhmig GA; Haitel A; Schmidbauer J; Marberger M; Remzi M
BJU Int; 2010 May; 105(9):1260-5. PubMed ID: 19818071
[TBL] [Abstract][Full Text] [Related]
25. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus.
Blute ML; Leibovich BC; Lohse CM; Cheville JC; Zincke H
BJU Int; 2004 Jul; 94(1):33-41. PubMed ID: 15217427
[TBL] [Abstract][Full Text] [Related]
26. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients.
Bani-Hani AH; Leibovich BC; Lohse CM; Cheville JC; Zincke H; Blute ML
J Urol; 2005 Feb; 173(2):391-4. PubMed ID: 15643178
[TBL] [Abstract][Full Text] [Related]
27. Bilateral renal masses: pathologic concordance and impact of temporal presentation.
Arnoux V; Fiard G; Descotes JL; Rambeaud JI; Long JA
Minerva Urol Nefrol; 2012 Dec; 64(4):287-93. PubMed ID: 23288216
[TBL] [Abstract][Full Text] [Related]
28. Bilateral synchronous sporadic renal tumors: pathologic concordance and clinical implications.
Patel AR; Lee BH; Campbell SC; Zhou M; Fergany AF
Urology; 2011 Nov; 78(5):1095-9. PubMed ID: 21937095
[TBL] [Abstract][Full Text] [Related]
29. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
30. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
31. Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
Beisland C; Hjelle KM; Reisaeter LA; Bostad L
Eur Urol; 2009 Jun; 55(6):1419-27. PubMed ID: 19147267
[TBL] [Abstract][Full Text] [Related]
32. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
Minervini A; Serni S; Giubilei G; Lanzi F; Vittori G; Lapini A; Carini M
Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
[TBL] [Abstract][Full Text] [Related]
33. Metastatic potential of a renal mass according to original tumour size at presentation.
Umbreit EC; Shimko MS; Childs MA; Lohse CM; Cheville JC; Leibovich BC; Blute ML; Thompson RH
BJU Int; 2012 Jan; 109(2):190-4; discussion 194. PubMed ID: 21557795
[TBL] [Abstract][Full Text] [Related]
34. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
[TBL] [Abstract][Full Text] [Related]
35. Surgical resection of brain metastases from renal cell carcinoma in 50 patients.
Wroński M; Arbit E; Russo P; Galicich JH
Urology; 1996 Feb; 47(2):187-93. PubMed ID: 8607231
[TBL] [Abstract][Full Text] [Related]
36. Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials.
Schwartz LH; Mazumdar M; Wang L; Smith A; Marion S; Panicek DM; Motzer RJ
Cancer; 2003 Oct; 98(8):1611-9. PubMed ID: 14534876
[TBL] [Abstract][Full Text] [Related]
37. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
[TBL] [Abstract][Full Text] [Related]
38. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival.
Taccoen X; Valeri A; Descotes JL; Morin V; Stindel E; Doucet L; Joulin V; Bocqueraz F; Coulange C; Rambeaud JJ; Fournier G; Mejean A;
Eur Urol; 2007 Apr; 51(4):980-7. PubMed ID: 17092632
[TBL] [Abstract][Full Text] [Related]
39. Delayed intervention of sporadic renal masses undergoing active surveillance.
Crispen PL; Viterbo R; Fox EB; Greenberg RE; Chen DY; Uzzo RG
Cancer; 2008 Mar; 112(5):1051-7. PubMed ID: 18286513
[TBL] [Abstract][Full Text] [Related]
40. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.
Thompson RH; Boorjian SA; Lohse CM; Leibovich BC; Kwon ED; Cheville JC; Blute ML
J Urol; 2008 Feb; 179(2):468-71; discussion 472-3. PubMed ID: 18076931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
